For me it is not questionable that NP will find a solution for finances since CYDY has almost no debts. Of course, the price is important, how much will it cost. And that's obviously where the solution is being chosen, maybe it will be the solution by the end of the year, and maybe even more serious by the time Leronlimab is launched. I believe that they have been working on this for a long time but they hoped it would be the easiest with the BLA.